Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT)

Conditions

Cannabis Dependence

What is the purpose of this trial?

The primary objective of this study is to evaluate the impact of N-acetylcysteine (NAC) 1200 mg versus matched placebo (PBO) twice daily, added to contingency management (CM), on cannabis use among treatment-seeking cannabis-dependent adults (ages 18-50).


Participation Guidelines

Age:
18 Years - 50 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
National Institute on Drug Abuse
Dates:
01/01/2014
Last Updated:
Study HIC#:
1310012843